This is a study to determine if flexibly-dosed Geodon is a safe and effective treatment for adolescents with schizophrenia. This international study is currently recruiting teens ages 13 years to 17 years old who have this condition.
In one of the biggest studies of its kind, researchers have established a way to more accurately predict the onset of psychosis in high... Read more »
At the 2008 convention, I was fortunate to catch up with Dr. Ken Duckworth, NAMI's medical director, and his colleague, Stephen... Read more »
The "100 Individuals with Schizophrenia" interview campaign continues. I talk now with Marvin Spieler, director of the Consumer... Read more »
The FDA approved Risperdal for the treatment of schizophrenia or bipolar I disorder in kids and teens. Risperdal can now be prescribed for... Read more »
The approval by the FDA for the use of Risperdal in the treatment of schizophrenia and bipolar disorder in children is a momentous event.... Read more »
This is a study to evaluate the long-term safety and effectiveness of Invega XR, given in flexible doses, to teens with schizophrenia. This national... Read more »
This is a study to evaluate the long-term safety and tolerability of flexible doses of extended-release Invega in teens who have been diagnosed with... Read more »
An expert panel that advises the U.S. Food and Drug Administration (FDA) has found the powerful antipsychotic drug Seroquel safe and effective for... Read more »
The release of the new movie "The Soloist" this week tells the story of Nathaniel Ayers, a promising string bass player whose musical training at the... Read more »
Scientists are studying the schizophrenia prodrome--the condition's early signs--to try to find a way to stop the thought disorder when it starts. A... Read more »